Ligand validation:2AOD

2NC: N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide

2NC is a Ligand Of Interest in 2AOD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2AOD_2NC_B_400	89%	42%	0.079	0.957	0.83	1.39	1	10	0	0	100%	1
2AOG_2NC_A_400	98%	56%	0.061	0.981	0.83	0.88	2	1	0	0	100%	0.9194
2AVM_2NC_B_300	95%	58%	0.077	0.982	0.69	0.91	1	2	1	0	100%	0.8007
2AOC_2NC_B_400	93%	53%	0.069	0.965	0.82	0.99	1	2	0	0	100%	0.9793
2AVQ_2NC_B_300	93%	18%	0.073	0.968	2.46	1.14	2	6	0	0	100%	0.8993
3BVA_2NC_B_200	84%	47%	0.105	0.968	0.98	1.08	3	4	0	0	100%	0.9061
6O5A_2NC_A_201	89%	5%	0.078	0.957	2	3.28	16	28	10	0	100%	0.963

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.